文献速递胃肠外科围术期管理与 ERAS

术前肌少症与直肠癌TaTME术后短期结局恶化相关

S184: preoperative sarcopenia is associated with worse short-term outcomes following transanal total mesorectal excision (TaTME) for rectal cancer.
PubMed 文献 · Surg Endosc · 2022-01-06

该回顾性队列分析纳入2014年4月至2020年5月接受TaTME的85例直肠癌患者,按性别最低三分位腰大肌指数(PMI)定义肌少症。肌少症患者30天并发症、再入院及术后小肠梗阻发生率均显著高于非肌少症者,校正性别后30天并发症风险约增四倍。

要点

  • 肌少症患者30天并发症发生率55%,非肌少症者24%(p=0.01)。
  • 肌少症患者30天再入院率41%,非肌少症者17%(p=0.014)。
  • 校正性别后肌少症与30天并发症相关(OR 4.44,95%CI 1.6-12.4)。

核心结论

  • 术前肌少症与直肠癌TaTME术后30天并发症增加相关,术前识别肌少症或为早期预康复干预提供机会。

研究设计与样本

  • 机构内回顾性队列分析,纳入2014年4月至2020年5月连续接受TaTME的直肠癌患者85例,按性别最低PMI三分位定义肌少症。

主要发现

  • 肌少症患者55%发生30天并发症,非肌少症者24%(p=0.01);肌少症患者41%需30天再入院,非肌少症者17%(p=0.014);肌少症患者术后小肠梗阻发生率10%,非肌少症者0%(p=0.04);校正性别后肌少症患者30天并发症OR为4.44(95%CI 1.6-12.4,p<0.05);两组基线特征无显著差异。

关键数值与推荐

  • 肌少症定义为按性别最低PMI三分位,肌少症组中位PMI为5.39(IQR 4.49-6.71);全队列中34%(n=29)为肌少症;全队列63%为男性,中位年龄59岁(IQR 51-65),中位BMI 28(IQR 24-32)。

临床怎么用

  • 原文建议术前识别肌少症或可为预康复项目早期干预提供机会;术后并发症可能通过延迟辅助化疗产生肿瘤学影响。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Malnutrition and deconditioning impact postoperative morbidity and mortality. Computed tomography (CT) body composition variables are used as markers of nutritional status and sarcopenia. The objective of this study is to evaluate the impact of sarcopenia, using CT variables, on postoperative outcomes following transanal total mesorectal excision (TaTME) for rectal cancer. METHODS: This was an institutional retrospective cohort analysis of consecutive rectal cancer patients who underwent TaTME between April 2014 and May 2020. Psoas muscle index (PMI) was calculated from diagnostic CT scans. Based on previous studies, patients in the lowest PMI tertile by gender were considered sarcopenic. Fisher's exact and Mann-Whitney U test were used to compare categorical and continuous variables, respectively. Readmission rates and postoperative complications were compared between groups. Backward stepwise logistic regression was used to determine the association between sarcopenia and 30-day postoperative complications. RESULTS: 85 patients were analyzed, of which 63% were male, with a median age of 59 (IQR: 51-65), and median BMI of 28 (IQR: 24-32). Of the entire cohort, 34% (n = 29) were sarcopenic (median PMI 5.39 IQR: 4.49-6.71). No significant difference in baseline characteristics between sarcopenic and nonsarcopenic patients were observed. 55% of sarcopenic patients experienced a complication within 30 days compared to 24% of nonsarcopenic patients (p = 0.01). 41% of sarcopenic patients required hospital readmission within 30 days compared to 17% of their nonsarcopenic counterparts (p = 0.014). Sarcopenic patients also experienced significantly higher rates of post-operative small bowel obstruction (10% vs. 0%, p = 0.04). Multivariable analyses identified that sarcopenic patients have a fourfold increase in odds of experiencing a 30-day postoperative complication (OR: 4.44, 95%CI: 1.6-12.4, p < 0.05) after adjusting for gender. CONCLUSION: Preoperative sarcopenia is associated with increased 30-day postoperative complications following TaTME for rectal cancer. Postoperative complications can have serious oncologic implications by delaying adjuvant chemotherapy. Therefore, preoperative recognition of sarcopenia prior to undergoing TaTME for rectal cancer may provide an opportunity for early intervention with prehabilitation programs.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Springer JE, Beauharnais C, Chicarilli D, et al. S184: preoperative sarcopenia is associated with worse short-term outcomes following transanal total mesorectal excision (TaTME) for rectal cancer. Surg Endosc. 2022. PMID: 34988741. doi:10.1007/s00464-021-08872-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。